Gross Profit - Corcept Therapeutics Inc (NASDAQ:CORT) - Alpha Spread

Corcept Therapeutics Inc
NASDAQ:CORT

Watchlist Manager
Corcept Therapeutics Inc Logo
Corcept Therapeutics Inc
NASDAQ:CORT
Watchlist
Price: 43.93 USD 1.5% Market Closed
Market Cap: 4.8B USD
Have any thoughts about
Corcept Therapeutics Inc?
Write Note

Corcept Therapeutics Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Corcept Therapeutics Inc
Gross Profit Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Corcept Therapeutics Inc
NASDAQ:CORT
Gross Profit
$561.1m
CAGR 3-Years
18%
CAGR 5-Years
16%
CAGR 10-Years
42%
Johnson & Johnson
NYSE:JNJ
Gross Profit
$60.1B
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Gross Profit
$35.4B
CAGR 3-Years
1%
CAGR 5-Years
16%
CAGR 10-Years
12%
Pfizer Inc
NYSE:PFE
Gross Profit
$39.7B
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
0%
Merck & Co Inc
NYSE:MRK
Gross Profit
$47.4B
CAGR 3-Years
16%
CAGR 5-Years
8%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
Gross Profit
$31.4B
CAGR 3-Years
17%
CAGR 5-Years
13%
CAGR 10-Years
7%

See Also

What is Corcept Therapeutics Inc's Gross Profit?
Gross Profit
561.1m USD

Based on the financial report for Jun 30, 2024, Corcept Therapeutics Inc's Gross Profit amounts to 561.1m USD.

What is Corcept Therapeutics Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
42%

Over the last year, the Gross Profit growth was 33%. The average annual Gross Profit growth rates for Corcept Therapeutics Inc have been 18% over the past three years , 16% over the past five years , and 42% over the past ten years .

Back to Top